All attending UK organisations

UK companies attending as part of the official delegation

(Click here to search profiles):

UK Exhibitors
Abzena, Almac Group, Barrington James, BBC Storyworks, Bird & Bird, GeneFirst, Sekisui, Symbiosis
See the list and locations here

UK Delegation
Almac Discovery, Arctoris, BiologIC Technologies, C4X Discovery, Crystec, Department for International Trade, Etcembly, Evgen Pharma, Intract Pharma, LSX, Mereo BioPharma, MetalloBio, OBN, Oxford Biomedica, OxSonics, PharmaVentures, Phastar, PrecisionLife, Results Healthcare, RNA Leaders, Rosemont Pharmaceuticals, SBA, Sekisui, SomaServe, Therakind.

Scotland
Carcinotech, Causeway Therapeutics, DeepMatter, Elasmogen, Ingenza, Symbiosis, Pneumagen, TC Biopharm.

Northern Ireland
AilseVax, Cumulus Neuroscience, CV6 Therapeutics, Diaceutics, Fusion Antibodies, Health Innovation Research Alliance Northern Ireland (HIRANI), ProAxSiS, Queen’s University Belfast, Re-vana Therapeutics, Sonrai Analytics, G&L Scientific.

Midlands
Birmingham University, Charnwood Molecular, Intelligent Omics, Oncimmune, Precision Health Technologies Accelerator.

Other UK companies associated with the delegation*:
Albumedix, Global Bio Fund

All attending UK companies:
4BIO Capital, 4d Pharma, AA Thornton, Abel & Imray, Abingworth, Abzena, 

Accord Healthcare, Achilles Therapeutics, Adaptimmune, ADVANZ Pharma, AilseVax, Airfinity, Alan Boyd Consultants, Albumedix, Alchemab Therapeutics, Almac Discovery, Almac Group, ALVOGEN, AMO Pharma, Anestpharma, Antiverse, Apollo Therapeutics, Aptamer Group, Arctoris, Arecor Therapeutics, Atelix, Autolus Therapeutics, Avillion, Babraham Institute Enterprise, Barrington James, BBC Storyworks, BenevolentAI, Bicycle Therapeutics, BiologIC Technologies, Bird & Bird, Black Swan Pharmaceuticals, Boult Wade Tennant, Brand Murray Fuller, C4X Discovery, Cambridge Enterprise, Cancer Research UK, Carcinotech, Cardiff University, Causeway Therapeutics, Cell and Gene Therapy Catapult, CHARM Therapeutics, Charnwood Molecular, Chugai Pharmaceutical Co, Clifton Life Sciences, Clinigen Group, COMPASS Pathways, Crystec Pharma, Cumulus Neuroscience, Curileum Discovery, CV6 Therapeutics, D. Young & Co, D5pharma, DC Biosciences, Deepmatter Group, Dementia Discovery Fund, Department for International Trade, Department for International Trade - Midlands region, Destiny Pharma, Diaceutics, Eip, Elasmogen, Eli Lilly and Company, Ellipses Pharma, Epitopea, Essential Pharma, Esya Labs, Etcembly, e-therapeutics, Eurofins Discovery, Evaluate, Eversheds Sutherland, Evgen, Evotec, Exscientia, Exvastat, Femtogenics, Ferring Pharmaceuticals, Foothold America, F-star Therapeutics, Fusion Antibodies, G&L Scientific, GE Healthcare, GE Healthcare Medical Diagnostics, GeneFirst, Genetic Microdevices, Genus, Gill Jennings & Every, Glenmark Pharmaceuticals Europe, Gowling WLG (UK), Grey Wolf Therapeutics, Grunenthal, GSK, Health Innovation Research Alliance - Northern Ireland, Healx, Heptares Therapeutics, Hikma Pharmaceuticals, IDEA Regulatory, Iksuda Therapeutics, Illingworth Research, Immunocore, Ingenza, IN-PART, Intelligent Omics, Intract Pharma, Intralink, Intron Health, Invest Northern Ireland, Johnson & Johnson, KGbio, Kyowa Kirin International, LabGenius, Lewis Silkin, Lift Biosciences, Livson Pharmaceutical Group, LSX (formerly Biotech and Money), M:M Bio, Mallinckrodt Pharmaceuticals, Mathys & Squire, Merck, Merck/ EMD, Mereo BioPharma, Mesenbio, Mestag Therapeutics, MetalloBio, Mewburn Ellis, Midatech Pharma, MIP Diagnostics, Mitsubishi Tanabe Pharma Corporation, MSD European Innovation Hub, Mundipharma International, Nanomerics, Nanosyrinx, NeoPhore, Norgine, Nuntius Therapeutics, OBN (UK), Oncimmune, Orbit Discovery, Orchard Therapeutics, Oval Medical Technologies, Oxford BioMedica, Oxford BioTherapeutics, Oximio, OxSonics Therapeutics, Patent Seekers, Pathios Therapeutics, Pencil Biosciences, Perfectus Biomed, PharmaVentures, Phastar, PhoreMost, PIVOT Digital Health, Pneumagen, Precision Health Technologies Accelerator, PrecisionLife, ProAxsis, Proimmune, QuantuMDx, Queens University Belfast, Quotient Sciences, RBW Consulting, Results Healthcare, Re-vana Therapeutics, Rosemont Pharmaceuticals, RPA Communications, SBA, Scendea, Schlich, Scottish Development International, Script IP, Secerna, Sekisui, Sentinel Oncology, Seqirus, Serentis, SGS Quay Pharmaceuticals, Silence Therapeutics, Simbec-Orion, Simcere Pharmaceutical Group, Sitryx Therapeutics, SomaServe, Sonrai Analytics, Sosei Group Corporation, Soterios, Standigm, Storm Therapeutics, SV Health Investors, Symbiosis Pharmaceutical Services, TC BioPharm, Terrapinn, The Wellcome Trust, Therakind, Torreya, Touchlight DNA Services, TranScrip, Transine Therapeutics, Treehill Partners, UK Bioindustry Association (BIA), University of Bath, University of Birmingham, University of Leeds, University of Manchester Innovation Factory, Vaccitech, Vectura Fertin Pharma, Venture Life, Viramal, Viiv Healthcare, WP Thompson, Yakumed.

(215).

*Delegation companies registered through BioPartner UK or DIT and saved $200 - $600.
*Associated companies requested a $200 discount code.

Join them here!